Our previous study examining the genomic impact of PTEN loss using TCGA data demonstrated that primary prostate tumors harboring PTEN deletions had enhanced levels of aneuploidy and non-synonymous mutations20. The gene discussed is PTEN; the disease is prostate neoplasm.